CIB2 Antibody

What is CIB2 and why is it important in research?

CIB2 is a 187 amino acid protein characterized by three EF-hand domains critical for calcium binding. It plays significant roles in:

• Auditory function: Essential for mechanotransduction in cochlear hair cells

• Muscle signaling: Binds integrin α7β1D and calcium in skeletal muscle

• Potential tumor suppression: Negatively regulates oncogenic signaling in ovarian cancer

CIB2 belongs to the calcium and integrin binding protein family (CIB1-4), with CIB2 and CIB3 specifically interacting with TMC1/2 through two distinct binding sites .

How do I select the appropriate CIB2 antibody for my research?

Selection should be based on:

• Target species compatibility: Available CIB2 antibodies detect proteins from various species:

  • Mouse monoclonal CIB2C12B11 detects mouse, rat, and human CIB2

• Application requirements:

  • Western blotting (WB): Most CIB2 antibodies are validated for WB

  • Immunoprecipitation (IP): Selected antibodies like CIB2C12B11 are IP-validated

  • Immunofluorescence: Custom antibodies have been developed for stereocilia visualization

• Epitope recognition: Consider whether N-terminal or C-terminal epitopes are preferable based on:

  • CIB2C12B11 targets the C-terminal region

  • Polyclonal antibodies targeting specific regions (e.g., 2nd EF-hand domain, aa 129-153) have been custom-generated for certain applications

How is CIB2 expression distributed across tissues?

CIB2 expression shows tissue specificity:

• Primary expression sites:

  • Developing central nervous system

  • Developing and adult skeletal muscle

  • Stereocilia and apical surface of cochlear hair cells

• Temporal expression patterns:

  • In auditory hair cells, CIB2 localization changes developmentally:

    • P7: Concentrated at basal body of kinocilium and hair bundle stereocilia

    • P10-P20: Located in tip region of stereocilia and apical surface around cuticular plate

  • Notably absent or minimally expressed in vestibular hair cell bundles

How can I validate CIB2 antibody specificity in my experimental system?

Rigorous validation includes:

• Genetic controls:

  • Use CIB2-/- knockout mice/cells as negative controls

  • The pattern of immunostaining should be absent in knockout tissues compared to wild-type

• Multiple antibody comparison:

  • Commercial antibodies may show non-specific binding (e.g., ab111908 from Abcam showed similar patterns in both wild-type and knockout mice)

  • Use multiple antibodies targeting different epitopes and compare staining patterns

• Recombinant protein controls:

  • Express tagged CIB2 constructs and confirm antibody detection

  • Use purified recombinant CIB2 protein as a positive control in western blots

• Cross-reactivity assessment:

  • Test against other CIB family members (CIB1, CIB3, CIB4) to confirm specificity

  • Perform peptide competition assays to verify epitope-specific binding

What are the optimal methods for studying CIB2-protein interactions?

Multiple complementary approaches should be employed:

• Co-immunoprecipitation (Co-IP):

  • Successfully used to demonstrate CIB2-TMC1 interactions

  • Protocol: Co-transfect GFP-tagged full-length TMC1 protein and 3xFlag-tagged CIB2 into HEK-293T cells, immunoprecipitate with anti-Flag beads, and detect TMC1-GFP using GFP antibodies

• Tandem affinity purification (TAP):

  • Effective for identifying novel interaction partners

  • Protocol overview:

    • Express SF-CIB2 in HEK293T cells for 48h

    • Lyse cells and clear lysate by centrifugation

    • Two-step purification: Strep-Tactin® Superflow® beads followed by anti-FLAG M2 agarose beads

    • Elute competitively using Desbiothin and FLAG® peptide

    • Precipitate eluate by methanol-chloroform for mass spectrometric analysis

• Structural analysis techniques:

  • AlphaFold2 modeling has successfully predicted CIB2-TMC1/2 interactions

  • Has revealed that CIB2 integrates into complexes with TMC1 and TMC2 through extensive interactions (22-24 hydrogen bonds and 21-23 salt bridges)

• Calcium binding assays:

  • ^45Ca^2+ binding can be assessed using GST-CIB2 fusion proteins

  • Protocols involve protein loading and separation by SDS-PAGE, transfer to polyvinylidene difluoride membrane, and calcium binding detection

How can I effectively study CIB2 function in mechanotransduction?

Advanced functional studies require:

• Electrophysiological approaches:

  • Whole-cell patch-clamp recordings can measure mechanoelectrical transduction (MET) currents in hair cells

  • Analysis of I-X curves and open probability (Popen) parameters in wild-type vs. mutant models

• Force probe techniques:

  • Used to quantify hair bundle deflection responses

  • Can detect differences in MET channel sensitivity to external force between wild-type and mutant CIB2

• Genetic models:

  • Utilize specific CIB2 mutations:

    • CIB2^-/- knockout mice show profound deafness

    • Cib2^R186W/R186W^ point mutation models show altered MET channel function

  • Comparative analysis of cochlear vs. vestibular hair cells can reveal tissue-specific functions

• Calcium imaging:

  • Allows visualization of calcium flux changes associated with CIB2 function

  • Can be combined with mechanical stimulation of stereocilia

Why might CIB2 antibody staining show inconsistent results in different tissue preparations?

Several factors can affect staining consistency:

• Fixation-dependent epitope masking:

  • CIB2 protein conformation may change with different fixatives

  • Recommendation: Compare 4% paraformaldehyde fixation with methanol or acetone fixation

  • Paraformaldehyde-fixed tissues may require antigen retrieval for optimal staining

• Calcium-dependent conformational changes:

  • CIB2 structure changes with calcium binding

  • Solution: Test fixation and staining in both calcium-present and calcium-chelated (EDTA) conditions

  • Some epitopes may only be accessible in specific calcium-binding states

• Developmental timing:

  • CIB2 localization changes during development (P7 vs. P10 vs. P20)

  • Ensure age-matching between experimental groups

  • Document precise developmental stage when interpreting localization data

• Antibody concentration optimization:

  • Titration experiments are essential

  • For polyclonal anti-CIB2 antibodies targeting the 2nd EF-hand domain, dilutions of 1:100-1:200 have been successful

What controls should be included when performing Western blots for CIB2?

Comprehensive controls include:

• Protein loading controls:

  • α-actinin (1:3000, clone EA-53, Sigma) has been successfully used

  • For tissue-specific normalization:

    • Cochlear tissue: Myosin VIIa

    • Muscle tissue: GAPDH or β-actin

• Molecular weight verification:

  • Expected molecular weight of human CIB2: ~21 kDa

  • GST-CIB2 fusion proteins: ~47 kDa

  • Flag-tagged CIB2: ~24 kDa

• Tissue-specific positive controls:

  • Skeletal muscle lysates provide reliable positive controls

  • For cochlear samples, pooled wild-type tissues are recommended

• Sample preparation optimization:

  • Protein denaturation protocol: Dilute 30 μg protein in loading buffer (61 mM Tris-HCl, pH 6.8, 0.05% bromphenol blue, 5% β-mercaptoethanol, 2% SDS, 10% glycerol)

  • Heat samples to 94°C for 5 min before loading on 15% acrylamide gels

What are the best methods for generating recombinant CIB2 for antibody validation and functional studies?

Optimized protocols include:

• Bacterial expression systems:

  • E. coli BL21(DE3) cells have been successfully used

  • Expression constructs:

    • Modified pET32a vector with N-terminal thioredoxin-His₆ tag

    • pGEX-6P-1 for GST fusion proteins

• Purification strategy:

  • Two-step purification recommended:

    • Initial Ni-NTA agarose affinity column for His-tagged proteins

    • Followed by size-exclusion chromatography (Superdex 200 column)

  • Buffer composition: 50 mM Tris (pH 7.8), 100 mM NaCl, 1 mM DTT, and either 1 mM EDTA or 0.5-3 mM CaCl₂

• Tag removal considerations:

  • HRV 3C protease digestion at 4°C overnight successfully removes thioredoxin-His₆ tags

  • Subsequent size-exclusion chromatography separates cleaved protein

• Verification methods:

  • Confirm proper folding through circular dichroism

  • Verify calcium binding through fluorescence or binding assays

  • Validate integrin binding through established assays

How do I interpret conflicting reports about CIB2's role in Usher syndrome versus non-syndromic deafness?

This requires careful analysis of:

What does the interaction between CIB2 and the TRiC/CCT chaperonin complex suggest about CIB2 function?

This emerging interaction suggests:

• Cytoskeletal regulation mechanisms:

  • TRiC/CCT complex is essential for folding actin and tubulin

  • CIB2 may influence cytoskeletal organization through this interaction

  • Particularly relevant in stereocilia where actin is abundant

• Ciliary connections:

  • CCT proteins are enriched at the base of primary cilia

  • Suggests potential role for CIB2 in cilia maintenance

  • May explain connections between auditory and potential visual phenotypes

• Cell cycle implications:

  • TRiC/CCT complex involvement in cell cycle regulation

  • CIB2 may influence cell proliferation through this pathway

  • Could relate to CIB2's potential tumor suppressor function in ovarian cancer

• Stress response considerations:

  • TRiC/CCT complex helps maintain proteostasis under stress

  • CIB2 may be involved in cellular stress responses

  • Relevant for understanding hair cell degeneration mechanisms

How should researchers reconcile the different functional roles of CIB2 in auditory versus non-auditory tissues?

A comprehensive analysis requires:

• Tissue-specific interaction partners:

  • In hair cells: Primary interaction with TMC1/2 in mechanotransduction

  • In muscle cells: Interaction with integrin α7β1D

  • In ovarian cancer cells: Interaction with sphingosine kinase 1 (SK1)

• Calcium-binding function analysis:

  • Three EF-hand domains mediate calcium binding

  • Calcium binding may induce different conformational changes depending on tissue-specific binding partners

  • Different calcium concentrations in various cellular compartments may affect function

• Evolutionary conservation assessment:

  • Compare CIB2 functions across species

  • Analyze whether auditory or non-auditory functions represent evolutionary adaptations

• Therapeutic targeting implications:

  • Auditory targeting: Focus on CIB2-TMC1/2 interactions

  • Cancer targeting: Focus on CIB2-SK1 axis

  • Skeletal muscle applications: Focus on integrin interactions

How might CIB2 antibodies be used to develop diagnostic or therapeutic approaches for deafness?

Strategic approaches include:

• Mutation-specific antibody development:

  • Generate antibodies that specifically recognize wild-type but not mutant CIB2

  • Could serve as diagnostic tools for certain DFNB48 mutations

  • May help identify potential carriers in at-risk populations

• Structure-guided therapeutic design:

  • CIB2 antibodies can help validate binding interfaces with TMC1/2

  • Structural information from antibody epitope mapping could inform small molecule design

  • Focus on compounds that stabilize CIB2-TMC1/2 interactions

• Drug screening applications:

  • CIB2 antibodies can serve as tools in high-throughput screens

  • Competition assays could identify compounds that enhance or mimic CIB2 function

  • Immunofluorescence-based screening could detect changes in CIB2 localization

• Gene therapy validation:

  • Antibodies essential for confirming expression of gene therapy constructs

  • Can verify correct subcellular localization of delivered CIB2 protein

What are the implications of CIB2's calcium-binding properties for studying auditory mechanotransduction?

This represents a critical area for investigation:

• Calcium-dependent conformational changes:

  • CIB2 likely undergoes structural shifts when binding calcium

  • These may regulate interactions with TMC1/2 and other partners

  • May explain calcium-dependent aspects of mechanotransduction

• Local calcium concentration effects:

  • Stereocilia tips have precise calcium regulation

  • CIB2 may act as a calcium buffer or sensor in this environment

  • Calcium imaging combined with CIB2 immunolocalization could reveal dynamic relationships

• Calcium wave propagation:

  • CIB2 may participate in calcium signal transmission

  • Particularly relevant in hair cells where calcium signals regulate adaptation

  • Could be studied using calcium indicators with CIB2 antibody labeling

• Pathology mechanisms:

  • CIB2 mutations may alter calcium binding properties

  • Could disrupt calcium homeostasis in stereocilia

  • Potentially triggering hair cell degeneration through calcium-dependent apoptosis

How can advanced microscopy techniques enhance CIB2 research using specific antibodies?

Cutting-edge approaches include:

• Super-resolution microscopy applications:

  • STORM or PALM imaging can resolve CIB2 localization within stereocilia at nanometer resolution

  • Dual-color imaging can precisely map CIB2 relative to TMC1/2 and other mechanotransduction components

  • Multi-color STORM can simultaneously visualize multiple proteins in the mechanotransduction complex

• Live-cell imaging approaches:

  • Antibody fragments (Fab, nanobodies) can be used for live imaging

  • Combine with genetically-encoded calcium indicators to correlate CIB2 dynamics with calcium flux

  • FRAP (Fluorescence Recovery After Photobleaching) can assess CIB2 mobility in stereocilia

• Correlative light-electron microscopy:

  • Immunogold labeling with CIB2 antibodies for TEM/SEM

  • Can precisely locate CIB2 relative to ultrastructural features

  • CLEM approaches can bridge fluorescence and electron microscopy data

• Expansion microscopy potential:

  • Physical expansion of specimens can enhance resolution of conventional microscopes

  • Particularly valuable for crowded structures like stereocilia

  • Can be combined with conventional CIB2 antibody immunofluorescence protocols